Skip to main content

Aggregator

Denali Therapeutics Reports Third Quarter 2026 Financial Results

6 days 20 hours ago
Denali Therapeutics Inc. reported its financial results for the third quarter ended September 30, 2026, highlighting net product revenue of $17.8 million for AVLAYAH in its second full commercial quarter. Fourth-quarter 2026 net product revenue is expected to be $30.0 million to

A look at the DOJ's effort to gain greater control over elections

6 days 20 hours ago
In recent months, the Trump administration and the Department of Justice have led an extraordinary effort to exert federal control over state-run elections. Nearly all of those efforts, so far, have been blocked or rejected by the courts. To discuss election security and the prospect of potential election interference, Geoff Bennett spoke with Rick Hasen and Juliette Kayyem.